友發集團(601686.SH):2021年度使用臨時閒置自有資金進行委託理財 單日最高餘額上限為20億元
格隆匯 12 月 31日丨友發集團(601686.SH)公佈,為充分利用公司自有資金,提高資金使用效率,公司第三屆董事會第二十九次會議審議通過了《關於預計2021年使用自有資金進行委託理財的議案》,同意公司(含子公司)2021 年度在不影響正常經營資金需求及資金安全的前提下,使用臨時閒置自有資金進行委託理財,購買商業銀行的理財產品單日最高餘額上限為20億元,在上述額度內資金可循環投資、滾動使用,授權公司財務負責人辦理相關事項,此次預計及授權期限自2021年1月1日起至2021年12月31日,單筆理財產品期限最長不超過12個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.